Prevalence and significance of plasma Epstein-Barr Virus DNA level in nasopharyngeal carcinoma

Epstein-Barr virus (EBV) DNA has been recognized as a promising tumor marker for nasopharyngeal carcinoma (NPC). This study aims to demonstrate the prevalence of plasma EBV DNA and its temporal correlation with treatment outcomes in the modern era. A total of 204 patients with Stage I–IVB NPC treate...

Descripción completa

Detalles Bibliográficos
Autores principales: Prayongrat, Anussara, Chakkabat, Chakkapong, Kannarunimit, Danita, Hansasuta, Pokrath, Lertbutsayanukul, Chawalit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2017
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5570077/
https://www.ncbi.nlm.nih.gov/pubmed/28204596
http://dx.doi.org/10.1093/jrr/rrw128

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5570077/
https://www.ncbi.nlm.nih.gov/pubmed/28204596
http://dx.doi.org/10.1093/jrr/rrw128

Ejemplares similares